All Pharma News
Wockhardt raises Rs 480 crore to pare debt, fund drug trial

Wockhardt raises Rs 480 crore to pare debt, fund drug trial
ECONOMIC TIMES
28 Mar 2024
Share Share
Wockhardt announces completion of Phase 3 pneumonia study of its WCK 4873

Wockhardt announces completion of Phase 3 pneumonia study of its WCK 4873
INDIAN PHARMA POST
12 Dec 2023
Share Share
Wockhardt to reduce debt against share pledge to 26% from 65% now in FY24

Wockhardt to reduce debt against share pledge to 26% from 65% now in FY24
ECONOMIC TIMES
28 Jun 2023
Share Share
Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22

Wockhardt’s Q4 FY23 three fold jump in EBITDA over Q4 FY22
INDIAN PHARMA POST
29 May 2023
Share Share
Wockhardt, its directors settle case with Sebi

Wockhardt, its directors settle case with Sebi
ECONOMIC TIMES
22 May 2023
Share Share
Wockhardt looks to roll out 2 vaccines from UK plant in 12 months

Wockhardt looks to roll out 2 vaccines from UK plant in 12 months
ECONOMIC TIMES
26 Feb 2023
Share Share
Wockhardt shuts US manufacturing plant

Wockhardt shuts US manufacturing plant
ECONOMIC TIMES
23 Feb 2023
Share Share
Pricing pressures in US, Europe to hit Indian Pharma’s profit margins

Pricing pressures in US, Europe to hit Indian Pharma’s profit margins
ECONOMICTIMES
05 Jan 2023
Share Share
Wockhardt promoters sell stake

Wockhardt promoters sell stake
INDIANPHARMAPOST
08 Dec 2022
Share Share
Morton Grove to discontinue operations at Illinois site due to mfg. issues

Morton Grove to discontinue operations at Illinois site due to mfg. issues
Tyler Patchen ENDPTS
23 Aug 2022
Share Share